FindMyKOL
Clinical trialNCT04017286RecruitingObservational

Relationship About Pregnancy Health and Offspring Developmental &Behavioral Outcomes

SponsorChen LiEnrollment3,000Children Behavior ProblemPregnancy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This topic puts forward a hypothesis: genetic and environmental factors such as major depressive disorder during pregnancy, nutritional status of vitamin A, D, E, and folic acid, intestinal microecology, and bisphenol A exposure, may affect the cognitive development level of the offspring through the genetic correlation with attention deficit hyperactivity disorder, developmental delay/intellectual disability, and major depressive disorder, allelic heterogeneity and pleiotropy of ITIH3 mediated by SNP and CACNB2, neurotransmitters like dopamine, and metabolic pathways, thereby increasing the risk of attention deficit hyperactivity disorder and developmental delay/intellectual disability prevalence on offspring. This topic planning from allelic heterogeneity and pleiotropy of attention deficit hyperactivity disorder and major depressive disorder mediated by SNP, neurotransmitters like dopamine, and metabolic pathways, explores deeply the influences on children's development level and the risk of common neurological disorder caused by genetic and environmental factors during pregnancy, looking for reasonable prevention, early diagnosis of biomarkers and therapeutic targets, in order to provide data support for further improvement and revision of national mother and infant healthcare policy .

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Chongqing First People'S Hospital of Liangjiang New Area

    Chongqing, Chongqing Municipality, China

    Not, yet, recruiting
  • the Central Hospital of Jiangjin District of Chongqing City

    Chongqing, Chongqing Municipality, China

    Not, yet, recruiting
  • the People'S Hospital of Yubei District of Chongqing City

    Chongqing, Chongqing Municipality, China

    Not, yet, recruiting
  • Wanzhou Health Center for Women and Children

    Chongqing, Chongqing Municipality, China

    Recruiting
  • the Maternal and Child Health Hospital of Hainan Province

    Haikou, Hainan, China

    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2019
Primary completion
31 Jul 2025
Completion
31 Dec 2028
Last update posted
1 Feb 2021
Registered enrollment
3,000
Registry id
NCT04017286

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.